Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biofil Chemicals submitted a quarterly compliance certificate for Q4 FY 2025-26 (ending 31 March 2026) as mandated under SEBI Regulation 74(5). The Registrar and Share Transfer Agent, Ankit Consultancy Private Limited, confirmed that securities received for dematerialization during the quarter were properly processed and communicated to depositories. Physical share certificates submitted for dematerialization were mutilated and cancelled, with depositories substituted as registered owners in the register of members within the required 15-day period. No specific numbers on volume of securities dematerialized were disclosed. This is a routine regulatory filing confirming adherence to SEBI's dematerialization norms.
No direct impact on shareholders or stock price. This is a standard compliance confirmation confirming proper processing of dematerialization requests during the quarter.